The Discounted Cash Flow (DCF) valuation of Fate Therapeutics Inc (FATE) is (104.90) USD. With the latest stock price at 1.12 USD, the upside of Fate Therapeutics Inc based on DCF is -9465.7%.
Based on the latest price of 1.12 USD and our DCF valuation, Fate Therapeutics Inc (FATE) is a sell. selling FATE stocks now will result in a potential gain of 9465.7%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.3% - 7.5% | 6.4% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (766.99) - (57.27) | (104.90) |
| Upside | -68580.9% - -5213.7% | -9465.7% |